NASDAQ:LTRN | Free Cash Flow | Lantern Pharma Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.77M
2025-12-31-$2.79M$1.00-$2.79M
2025-03-31-$4.38M$1,159.00-$4.38M
2024-12-31-$3.97M$3,083.00-$3.97M
2024-03-31-$3.07M$2,217.00-$3.07M
2023-12-31-$3.39M$5,081.00-$3.39M
2023-03-31-$3.76M$8,876.00-$3.77M
2022-12-31-$2.67M$6,955.00-$2.68M
2022-03-31-$3.33M
2021-12-31-$2.04M$1.00-$2.04M
2021-03-31-$2.14M
2020-12-31-$1.57M
2020-03-31-$703,048.00
2019-12-31-$708,876.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$15.68M$1,715.00-$15.68M
2024-12-31-$17.81M$12,595.00-$17.83M
2023-12-31-$14.35M$18,734.00-$14.37M
2022-12-31-$12.77M$27,844.00-$12.8M
2021-12-31-$10.59M$15,499.00-$10.61M
2020-12-31-$5.65M
2019-12-31-$2.13M